Antifungal proteins from yeasts for recurrent vaginal yeast infection treatment
Innovative antifungal proteins from yeasts offer a novel approach to treat recurrent vaginal yeast infections. These proteins, with optimal activity at vaginal pH levels, present a unique mechanism distinct from current treatments, promising enhanced efficacy.
Overview
This solution leverages antifungal proteins produced by yeasts, specifically targeting recurrent vaginal yeast infections. These proteins, particularly the K1 toxin from Saccharomyces cerevisiae, exhibit optimal antifungal activity at the low pH conditions of the vaginal mucosa, where traditional antifungals often fail. They are non-toxic to human cells and effective against strains like Candida glabrata, thereby offering a promising alternative to existing topical and systemic treatments.
Technical specifications
Key features:
- Antifungal proteins maintain stability and activity at pH ~4.5, ideal for vaginal environments.
- Non-toxic to human cells, reducing potential side effects of treatment.
- Specifically targets Candida glabrata, a common cause of recurrent infections.
- Potential for development into probiotic yeast strains for enhanced therapeutic application.
Development approach:
- Creating recombinant Saccharomyces cerevisiae strains for increased K1 toxin production.
- Utilizing high-throughput robotic screening and genetic modification to enhance yeast strain resistance to K1.
Technology readiness level
The technology is currently at TRL 5, having been validated in relevant environments. The next steps involve developing production pipelines for recombinant K1 and pursuing clinical trials to further verify efficacy and safety in treating vaginal candidiasis.
About University of Idaho
Founded as Idaho’s land‑grant, the University of Idaho is a comprehensive public research university with a statewide footprint anchored in Moscow. Industry engages through a Post Falls research park that co‑locates companies with faculty, multi‑campus centers in Boise, Coeur d’Alene and Idaho Falls, and an Extension network active in 42 counties. Proximity and formal agreements with Idaho National Laboratory provide a direct conduit to national‑lab expertise and shared facilities in Idaho Falls. Research is backed by competitive federal funding from agencies such as the National Science Foundation, U.S. Department of Agriculture and the Department of Energy. A dedicated technology transfer office supports IP strategy, licensing and startup formation.
Inquire about this partnering listing
Industry applications
delivered to your inbox.